T-lymphocyte subset abnormalities in the Guillain-Barré syndrome

por Dahle, C., Vrethem, M., Ernerudh, J.
Publicado 1994

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

por Tedeholm, H, Lycke, J, Skoog, B, Lisovskaja, V, Hillert, J, Dahle, C, Fagius, J, Fredrikson, S, Landtblom, A-M, Malmeström, C, Martin, C, Piehl, F, Runmarker, B, Stawiarz, L, Vrethem, M, Nerman, O, Andersen, O
Publicado 2013

Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis

por Biström, M., Jons, D., Engdahl, E., Gustafsson, R., Huang, J., Brenner, N., Butt, J., Alonso‐Magdalena, L., Gunnarsson, M., Vrethem, M., Bender, N., Waterboer, T., Granåsen, G., Olsson, T., Kockum, I., Andersen, O., Fogdell‐Hahn, A., Sundström, Peter
Publicado 2020

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association...

por Vågberg, M., Axelsson, M., Birgander, R., Burman, J., Cananau, C., Forslin, Y., Granberg, T., Gunnarsson, M., von Heijne, A., Jönsson, L., Karrenbauer, V. D., Larsson, E.‐M., Lindqvist, T., Lycke, J., Lönn, L., Mentesidou, E., Müller, S., Nilsson, P., Piehl, F., Svenningsson, A., Vrethem, M., Wikström, J.
Publicado 2016